Invention Application
US20160144028A1 COMBINATION THERAPY USING DUAL INHIBITOR OF C-MET AND EGFR AND IGF-1R INHIBITOR
有权
使用C-MET和EGFR和IGF-1R抑制剂的双重抑制剂的联合治疗
- Patent Title: COMBINATION THERAPY USING DUAL INHIBITOR OF C-MET AND EGFR AND IGF-1R INHIBITOR
- Patent Title (中): 使用C-MET和EGFR和IGF-1R抑制剂的双重抑制剂的联合治疗
-
Application No.: US14949303Application Date: 2015-11-23
-
Publication No.: US20160144028A1Publication Date: 2016-05-26
- Inventor: Jimin Lee , Bo Gyou Kim , Seungja Oh , Kyung Ah Kim , Powei Lin , Saet Byoul Lee
- Applicant: Samsung Electronics Co., Ltd.
- Priority: KR10-2014-0163791 20141121
- Main IPC: A61K39/395
- IPC: A61K39/395 ; G01N33/574 ; A61K31/4985
Abstract:
A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met and EGFR (hereinafter, ‘c-Met/EGFR dual inhibitor’) and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met/EGFR dual inhibitor
Public/Granted literature
- US09943596B2 Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor Public/Granted day:2018-04-17
Information query
